metabolomics
U of Alberta Researchers Win $120K Grant to Develop Metabolite-Based Lung Cancer Test
BioMark Diagnostics has been collaborating on the test with the Metabolomics Innovation Centre at the University of Alberta since early 2015.
Centogene, Alnylam Pharmaceuticals Partner on Biomarker Study of Transthyretin Amyloidosis
The study, called TRAMmoniTTR, will longitudinally monitor the clinical status of both symptomatic and asymptomatic participants with variants in the TTR gene.
Exagen, Ohio State Innovation Foundation Partners to Develop Fibromyalgia Test
The novel blood test uses vibrational spectroscopy and metabolomic analysis to differentiate patients with fibromyalgia from those with other autoimmune disorders.
If the results are validated, investigators believe the method could help diagnose patients without the need for a needle biopsy and with fewer false positives.
German Dx Firm InfanDx Nabs €1M to Develop Neonatal Encephalopathy CDx
InfanDx is taking the lead on the project and will be joined by researchers from University Hospital Essen, Clinic for Pediatrics I, and Furtwangen University.